International medical cannabis offers compelling growth driven by expanding regulated markets in Europe, Australia, and Israel, coupled with increasing patient adoption and robust EU-GMP supply chains, despite ongoing regulatory complexities.
14 tickers·$2.89B market cap
10D-8.43%#1,344of 1,461 themes/1,461#3of 6 in Cannabis/6 Cannabis